Skip to content
ChickenStockChickenStock
ResearchFilings
← Disclosures

JW Pharmaceutical001060

JW Pharmaceutical (001060) Preliminary Earnings, Nov 4, 2026

Filing date ·

JW Pharmaceutical reported preliminary Q3 2026 results (separate): Revenue of KRW 211.1 billion (+6.3% year over year), operating profit of KRW 29.1 billion (-…

Sign in to read this filing in detail

Continue to the filing details and any available analysis after signing in.

Filing lists and official source links are available without signing in.